Olanzapine improves chemotherapy-induced nausea and vomiting and leads to higher complete response rates, reduced need for rescue medications, and improved quality of life in patients with solid ...

The addition of olanzapine (Zyprexa) to standard antiemetic therapy among patients receiving highly emetogenic chemotherapy provides better nausea and vomiting relief across subgroups at high risk for ...

Please provide your email address to receive an email when new articles are posted on . Patients assigned olanzapine achieved better nausea control than those assigned observation. More patients ...

A recent review of research found that ginger is an effective non-drug way to manage chemotherapy-induced nausea and vomiting. Research supports the use of ginger (a type of spice that is commonly ...

(HealthDay News) — Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting. Varubi, a substance P/neurokinin-1 ...

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR–Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer Study ...

Low-dose olanzapine plus standard antiemetic therapy may be the preferred prophylactic regimen for patients receiving highly emetogenic chemotherapy, according to a presentation at the San Antonio ...

A recently conducted study found that for some patients, chemotherapy-induced hiccups were worse than nausea and vomiting. Hiccups lasting for days, weeks or longer may be an underreported side effect ...